AK Medical Holdings Limited provides consolidated earnings guidance for the year ended 31 December 2022. For the period, The company expects to record an increase in revenue by over 35% for the year ended 31 December 2022 as compared to the revenue for the year ended 31 December 2021; and the Board expects to record a significant increase in net profit attributable to Shareholders by over 100% for the year ended 31 December 2022 as compared to the net profit attributable to Shareholders for the year ended 31 December 2021.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.62 HKD | -0.35% | +0.18% | -9.74% |
04-22 | AK Medical Holdings' Surgical Robot Gets NMPA's Nod | MT |
04-18 | Eric Wang to Retire as an Independent Non-Executive Director of AK Medical Holdings Limited | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.74% | 810M | |
+10.86% | 124B | |
-5.42% | 11.17B | |
+4.17% | 9.17B | |
-21.47% | 4.71B | |
+8.77% | 3.44B | |
-6.03% | 2.88B | |
-12.05% | 2.11B | |
-7.83% | 2.09B | |
-22.84% | 1.8B |
- Stock Market
- Equities
- 1789 Stock
- News AK Medical Holdings Limited
- AK Medical Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2022